New treatments and perspectives in metastatic TNBC with PARP Inhibitors.
Benjamin VERRET
Oncologist, Villejuif, France
Oncologist, Villejuif, France
Robotic and the future of breast cancer surgery.
Ahmad MATALKAH
Screening: How to overcome social reluctance and superstitions.
Anas Alexis CHEBIB
What are the opportunities brought by the BCU and what are the contributions of genetics to the management of breast cancer?
Pascal PUJOL
Chairman of the Genetic department, University Hospital, Montpellier, France
What are the options in HER2 postive breast cancer treatments are we moving to t-DXd in first line?
Hassan GHAZAL
oncologist, Dubai